Genscript Biotech Corporation

SEHK:1548 Stok Raporu

Piyasa değeri: HK$28.1b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Genscript Biotech Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Genscript Biotech şirketinin toplam hissedar öz sermayesi $1.8B ve toplam borcu $877.2M olup, bu da borç-öz sermaye oranını 48.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $3.3B ve $1.5B dir.

Anahtar bilgiler

48.1%

Borç/özkaynak oranı

US$877.17m

Borç

Faiz karşılama oranın/a
NakitUS$1.88b
EşitlikUS$1.82b
Toplam yükümlülüklerUS$1.51b
Toplam varlıklarUS$3.33b

Son finansal sağlık güncellemeleri

Recent updates

Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

Oct 01
Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

Sep 16
What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

After Leaping 44% Genscript Biotech Corporation (HKG:1548) Shares Are Not Flying Under The Radar

Aug 02
After Leaping 44% Genscript Biotech Corporation (HKG:1548) Shares Are Not Flying Under The Radar

Slammed 28% Genscript Biotech Corporation (HKG:1548) Screens Well Here But There Might Be A Catch

Jun 05
Slammed 28% Genscript Biotech Corporation (HKG:1548) Screens Well Here But There Might Be A Catch

A Look At The Fair Value Of Genscript Biotech Corporation (HKG:1548)

May 10
A Look At The Fair Value Of Genscript Biotech Corporation (HKG:1548)

Is Genscript Biotech (HKG:1548) A Risky Investment?

Apr 13
Is Genscript Biotech (HKG:1548) A Risky Investment?

Investors Appear Satisfied With Genscript Biotech Corporation's (HKG:1548) Prospects As Shares Rocket 29%

Mar 13
Investors Appear Satisfied With Genscript Biotech Corporation's (HKG:1548) Prospects As Shares Rocket 29%

Genscript Biotech Corporation (HKG:1548) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jan 26
Genscript Biotech Corporation (HKG:1548) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Is Genscript Biotech (HKG:1548) A Risky Investment?

Nov 21
Is Genscript Biotech (HKG:1548) A Risky Investment?

Is Genscript Biotech (HKG:1548) A Risky Investment?

Aug 22
Is Genscript Biotech (HKG:1548) A Risky Investment?

Time To Worry? Analysts Just Downgraded Their Genscript Biotech Corporation (HKG:1548) Outlook

Apr 04
Time To Worry? Analysts Just Downgraded Their Genscript Biotech Corporation (HKG:1548) Outlook

Analysts Have Been Trimming Their Genscript Biotech Corporation (HKG:1548) Price Target After Its Latest Report

Apr 03
Analysts Have Been Trimming Their Genscript Biotech Corporation (HKG:1548) Price Target After Its Latest Report

Is Genscript Biotech (HKG:1548) A Risky Investment?

Apr 02
Is Genscript Biotech (HKG:1548) A Risky Investment?

Genscript Biotech Corporation (HKG:1548) Shares Could Be 25% Below Their Intrinsic Value Estimate

Feb 07
Genscript Biotech Corporation (HKG:1548) Shares Could Be 25% Below Their Intrinsic Value Estimate

What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

Dec 14
What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

Genscript Biotech Corporation (HKG:1548) Shares Could Be 22% Below Their Intrinsic Value Estimate

Nov 09
Genscript Biotech Corporation (HKG:1548) Shares Could Be 22% Below Their Intrinsic Value Estimate

Is Genscript Biotech (HKG:1548) Using Debt Sensibly?

Oct 22
Is Genscript Biotech (HKG:1548) Using Debt Sensibly?

Health Check: How Prudently Does Genscript Biotech (HKG:1548) Use Debt?

Apr 03
Health Check: How Prudently Does Genscript Biotech (HKG:1548) Use Debt?

Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?

Oct 03
Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?

Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Sep 07
Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Estimating The Fair Value Of Genscript Biotech Corporation (HKG:1548)

Aug 16
Estimating The Fair Value Of Genscript Biotech Corporation (HKG:1548)

Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Jun 03
Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Is Genscript Biotech Corporation (HKG:1548) Trading At A 49% Discount?

May 13
Is Genscript Biotech Corporation (HKG:1548) Trading At A 49% Discount?

Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

Apr 16
Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?

Mar 20
Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?

Are Insiders Selling Genscript Biotech Corporation (HKG:1548) Stock?

Feb 13
Are Insiders Selling Genscript Biotech Corporation (HKG:1548) Stock?

Did The Underlying Business Drive Genscript Biotech's (HKG:1548) Lovely 753% Share Price Gain?

Jan 09
Did The Underlying Business Drive Genscript Biotech's (HKG:1548) Lovely 753% Share Price Gain?

Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?

Dec 05
Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 1548 'nin kısa vadeli varlıkları ( $2.2B ) kısa vadeli yükümlülüklerini ( $533.0M ) aşıyor.

Uzun Vadeli Yükümlülükler: 1548 şirketinin kısa vadeli varlıkları ( $2.2B ) uzun vadeli yükümlülüklerini ( $974.7M ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 1548 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 1548 şirketinin borç/öz sermaye oranı son 5 yılda 4.2% seviyesinden 48.1% seviyesine yükseldi.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: 1548 şirketinin mevcut serbest nakit akışına göre 3 yıldan fazla bir süre için yeterli nakit pistine sahip olduğu belirtiliyor.

Tahmini Nakit Akışı: 1548 tarihsel oranlara göre serbest nakit akışı büyümeye veya küçülmeye devam ederse yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.


Sağlıklı şirketleri keşfedin